Skip to main content

Month: April 2024

Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments

Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities. The converted common stock is included in the company’s total 165 million outstanding shares. The Tevogen.ai initiative aims to harness the immense potential of AI to enhance drug discovery, development, manufacturing, distribution, and patient access.WARREN, N.J., April 26, 2024 (GLOBE NEWSWIRE) — Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology. Dear Fellow Stockholders: In anticipation of the filing of our annual financial statements, I would like to provide our investors with a few reflections on anticipated financial results. First,...

Continue reading

Press Release on April 26, 2024, Relating to the Filing of the Draft Response Document Prepared by BELIEVE in response to the simplified offer on the shares of Believe

This document is an unofficial English-language translation of the press release relating to the filing of the draft response document (projet de note en réponse) which was filed with the French Autorité des marchés financiers on April 26, 2024, and which remains subject to its review. In the event of any discrepancies between this unofficial English-language translation and the official French press release, the official French press release shall prevail. PRESS RELEASE ON APRIL 26, 2024, RELATING TO THE FILING OF THE DRAFT RESPONSE DOCUMENT PREPARED BY  IN RESPONSE TO THE SIMPLIFIED TENDER OFFER  ON THE SHARES OF BELIEVE INITIATED BY UPBEAT BIDCO This press release has been prepared by Believe and distributed in accordance with the provisions of article 231-26 of the General Regulations of the Autorité des marchés financiers (the “AMF“)...

Continue reading

Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer

CLEVELAND, OHIO, April 26, 2024 (GLOBE NEWSWIRE) — Range Impact, Inc. (OTC: RNGE) (“Range Impact” or “Company”), an impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in economically disadvantaged communities throughout Appalachia, announces the transition of Dr. Brandon Zipp, Chief Science Officer, and Richard McKilligan, Chief Financial Officer and Counsel, from Range Impact to Graphium Biosciences, Inc. (“Graphium”), a wholly-owned subsidiary of Range Impact, in connection with a proposed divestiture and recapitalization of Graphium. Additionally, Range Impact has promoted Patricia Missal from her role as Corporate Controller to Chief Financial Officer. From 2012 to 2021, Range Impact (then known as Stevia First Corp. and subsequently as Vitality Biopharma, Inc.) was exclusively an early-stage...

Continue reading

Nuwellis Announces Pricing of $2.7 Million Public Offering

MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. Each share of common stock (or prefunded warrant in lieu thereof) is being sold together with one warrant to purchase one and a half shares of common stock. The warrants will have an exercise price of $0.40 per share, are exercisable immediately upon issuance, and will expire five years following the date...

Continue reading

Vilkyskiu pienine AB annual information for the year 2023

Vilkyskiu pienine AB introduce financial statement for the year 2023  Vilkyskiu pienine AB approved by the Ordinary General Meeting of the Shareholders. The Company informs that the Ex-Date, since which Vilkyskiu pienine AB shares (VLP1L, ISIN kodas LT0000127508) bought via stock exchange with settlement cycle T+2 do not provide the right to dividends for year 2023, is 10 May 2024.           Vilija Milaseviciute          Economics and Finance Director          Phone: +370 441 55 102Attachmentabvilkyskiupienine-2023-12-31-en

Continue reading

Wrap Technologies Announces Exciting New Distributor Agreement with Kokusai Security

MIAMI, April 26, 2024 (GLOBE NEWSWIRE) —  Wrap Technologies, Inc. (NASDAQ: WRAP), a global leader in innovative public safety technologies, is proud to announce a strategic distribution partnership with Kokusai Security Service, a leading provider of security solutions in the Asia-Pacific region. This partnership marks a significant milestone for both companies, as they join forces to bring cutting-edge public safety solutions to law enforcement agencies and security professionals across the region. Under this agreement, Kokusai Security will serve as a key distributor of Wrap Technologies’ flagship products, including the BolaWrap remote restraint device, Wrap Reality VR Training system, and Intrensic Body Worn Cameras and Cloud Services Solutions in designated areas within the region. Leveraging Kokusai Security’s...

Continue reading

HWH International Inc. enters into a joint venture to build its travel business in Asia

Bethesda, MD, April 26, 2024 (GLOBE NEWSWIRE) — HWH International Inc. (“HWH”) (Nasdaq: HWH) announced today that it has entered into a joint venture through its subsidiary Health Wealth Happiness Pte Ltd. (“HWHPL”), with Mr. Chen Ziping (“Mr. Chen”), an experienced entrepreneur in the travel industry, and Mr. Chan Heng Fai Ambrose, HWH’s Executive Chairman (“Mr. Chan”). This new joint venture is part of HWH’s strategy of building its travel business in Asia. The joint venture company (referred to here as the “JVC”) will be known as HapiTravel Holding Pte. Ltd. The JVC will be initially owned as follows: (a) HWHPL will hold 19% of the shares in the JVC; (b) Mr. Chan will hold 11%; and (c) the remaining 70% of the shares in the JVC are to be held by Mr. Chen. By forging strategic alliances, the JVC will aim to expand its market...

Continue reading

SOLOWIN HOLDINGS Strengthens Partnership with OSL to Facilitate Hong Kong’s Innovative Spot Virtual Asset ETFs with In-Kind Subscription and Redemption

HONG KONG, April 26, 2024 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a securities brokerage company that offers comprehensive financial services primarily to Chinese investors, today announced that the Company, through its subsidiary, Solomon JFZ (Asia) Holdings Limited (“Solomon”), strengthened the partnership with OSL Digital Securities (“OSL”), the digital asset platform of OSL Group (863.HK) – Hong Kong’s only publicly listed company fully dedicated to digital assets, to facilitate the in-kind subscription and redemption processes essential for the successful deployment and management of Hong Kong’s first spot virtual asset exchange-traded funds (“ETFs”). Solomon is the first batch of SFC-approved participating dealer of this innovative in-kind subscription and redemption...

Continue reading

Decisions taken at the Ordinary General Meeting of the Shareholders, held on 26 April 2024

The following decisions were taken at the Ordinary General Meeting of Shareholders of Vilkyskiu pienine AB which was held on the 26 April 2024: Item 1 of the Agenda: Regarding Company’s Consolidated annual report for 2023. Heard. Item 2 of the Agenda: Regarding independent auditor‘s conclusion on the Company’s consolidated and separated financial Statements for 2023. Heard. Item 3 of the Agenda: Regarding comments and proposals of Company’s Supervisory Board. Comments and proposals heard. Item 4 of the Agenda: Regarding the approval of Company’s separated and consolidated financial statement for the year 2023. Resolution: Company’s separated and consolidated financial statements for the year 2023 has been approved. Item 5 of the Agenda: Regarding the approval of the remuneration report of the Company for 2023,...

Continue reading

The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended

Uponor Corporation, Stock Exchange Release, April 26, 2024, 4.15 p.m. EET The arbitral tribunal has confirmed GF’s redemption right over the minority shares in Uponor and trading in Uponor’s shares has been suspended The arbitral tribunal appointed by the Redemption Committee of the Finland Chamber of Commerce in connection with the redemption proceedings concerning the minority shares in Uponor Corporation (“Uponor”) has in its interim award confirmed that Georg Fischer AG (“GF”) has the right to redeem the minority shares in Uponor and that GF has the right to obtain title to the minority shares by posting a security approved by the arbitral tribunal for the payment of the redemption price and the possible interest accruing thereon. Uponor announced on March 22, 2024, that Uponor has resolved to apply for the termination of public trading...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.